Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Kazakhstan

Kazakhstan

The Other Vaccines market in Kazakhstan is expected to witness substantial growth in the coming years.
According to projections, the revenue in this market is set to reach US$20.89m by 2024.
Furthermore, it is anticipated that the market will exhibit a compound annual growth rate (CAGR 2024-2029) of 10.73%, resulting in a market volume of US$34.77m by 2029.
When compared globally, it is noteworthy that United States is expected to generate the highest revenue in this market, with an estimated amount of US$24,730.00m in 2024.
The demand for other vaccines in Kazakhstan is growing rapidly due to increased awareness about the importance of preventive healthcare among the population.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Kazakhstan has been experiencing steady growth in recent years.

Customer preferences: Kazakhstan has a population of over 18 million people, with a significant number of them being children. As such, vaccines are in high demand in the country. The government has implemented a mandatory vaccination program for children, which has contributed to the growth of the market.

Trends in the market: One of the main drivers of growth in the Other Vaccines market in Kazakhstan is the increasing awareness of the importance of vaccination. The country has been experiencing a rise in vaccine-preventable diseases, which has led to an increase in demand for vaccines. Additionally, the COVID-19 pandemic has highlighted the importance of vaccines, leading to an increase in demand for other types of vaccines as well.

Local special circumstances: Kazakhstan is a developing country, and as such, there are several challenges facing the healthcare system. One of the main challenges is the lack of access to healthcare in rural areas. This has led to a concentration of healthcare facilities in urban areas, which can make it difficult for people living in rural areas to access vaccines. Additionally, there is a lack of awareness about the importance of vaccines in some parts of the country, which can lead to lower vaccination rates.

Underlying macroeconomic factors: Kazakhstan has a growing economy, which has led to an increase in healthcare spending. The government has been investing in the healthcare system, which has contributed to the growth of the Other Vaccines market. Additionally, the country has been experiencing a demographic shift, with an increasing number of children being born. This has led to an increase in demand for vaccines, which has contributed to the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.